References
Brooks ED, Landau DJ, Everitt JI et al (2018) Long-term complications of glycogen storage disease type Ia in the canine model treated with gene replacement therapy. J Inherit Metab Dis. https://doi.org/10.1007/s10545-018-0223-y
Lee YM, Conlon TJ, Specht A et al (2018) Long-term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia. J Inherit Metab Dis. https://doi.org/10.1007/s10545-018-0199-7
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Elizabeth D. Brooks, Priya Kishnani, and Dwight D. Koeberl have no conflicts of interest to report.
Additional information
Communicating Editor: Terry Derks
Rights and permissions
About this article
Cite this article
Brooks, E.D., Kishnani, P.S. & Koeberl, D.D. Letter to the Editors: Concerning “Long-term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia” by Lee et al.. J Inherit Metab Dis 41, 913–914 (2018). https://doi.org/10.1007/s10545-018-0248-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-018-0248-2